1.
Cancer UK. http://info.cancerresearchuk.org/cancerstats.
Accessed January 2011.
2.
Plataniotis G,
Castiglione M. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Annals of Oncology (2010) 21:41-45.
3. Jemal A,
Siegel R,
Ward E et al. Cancer statistics. CA Cancer J Clin (2009) 59:225-249.
4. Sohaib SA,
Verma H,
Attygalle AD,
Ind TEJ. Imaging of Uterine Malignancies. Semin Ultrasound CT MRI (2010) 13:377-387.
5. Jelbert AE,
Bharwani N,
Rockall AG. The role of imaging in the management of endometrial cancer. CME Journel of Gynecologic Oncology (2008) 13:52-58.
6.
Mutch D. Meeting Report: The new FIGO staging system for cancers of the vulva,
cervix,
endometrium and sarcomas.
Gynecologic Oncology (2009)115:325-328.
7. Baekelandt MM,
Castiglione M.
Endometrial carcinoma ESMO Clinical Recommendations for diagnosis,
treatment and follow-up. Annals of Oncology.
(2010) 20,
Suppl 4:iv29-iv31.
8. McMeekin DS,
Lashbrook D,
Gold M et al.
Nodal distribution and its significance in FIGO stage IIIc endometrial cancer.
Gynecologic Oncology (2001) 82:375-9.
9.
Morrow CP,
Bundy BN,
Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Onoclogy Group study. Gynecologic Oncology (1991) 40:55-65.
10. Kinkel K,
Forstner R,
Danza FM et al.
Staging of endometrial cancer with MRI: Guidelines of the European society of Urogenital Imaging. Eur Radiol (2009) 19:565–1574
11.
Sala E,
Wakely S,
Senior E,
et al.
MRI of malignant neoplasms of the uterine corpus and cervix. American Journel of Roentgenology (2007) 188:1577-1587.
12. Yamashita Y,
Mizutani H,
Torshima M et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR AM J Roentgenol.
161:595-9.
(1993).
13.
Hricak H,
Stern JL,
Fisher MR,
et al. Endometrial carcinoma staging of MR imaging. Radiology (1987) 162(2):297-305
14.
Hardesty LA,
Sumkin JH,
Hakim C et al. The ability of helical CT to preoperatively stage endometrial carcinoma. The American Journel of Roentgenology (2001) 176:603-606.
15.
Sala E,
Crawford R,
Senior E et al. Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma.
Int J Gynecol Cancer (2009)19:141–146.
16. Kinkel K. Pitfalls in staging uterine neoplasm with imaging: a review. Abdom Imaging (2006) 31:164-73.
17. Sala E,
Wakely S,
Senior E,
Lomas D. MRI of malignant neoplasms of the uterine corpus and cervix.
American Journel of Roentgenology 188:1577-87 (2007).
18. Manfredi R,
Gui B,
Maresca G,
et al. Endometrial cancer: magnetic resonance imaging. Abdom Imaging (2005) 30:626-36.
19. Koyama T,
Tamai K,
Togashi K. Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol (2007) 17:2009-2019.
20 Manfredi R,
Mirk P,
Maresca G,
et al. Local-regional staging of endometrial carcinoma: Role of MR imaging in surgical planning.
Radiology (2004) 231:372-378.
21. Rockall AG,
Sohaib SA,
Harisinghani MG,
et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol (2005) 23:2813-2821.